CHU Bobo Dioulasso Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2014
NCT01905059
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Hopital de Jour CHU Bobo Dioulasso